Back to top
more

Vanguard S&P 500 Value ETF: (VOOV)

(Real Time Quote from BATS) As of Feb 27, 2026 11:00 AM ET

$212.97 USD

212.97
16,617

-1.57 (-0.73%)

Volume: 16,617

Zacks ETF Rank

This is our ETF rating system that serves as a timeliness indicator for ETFs over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

See all the Top Ranked ETFs here - The complete list of all the top ranked ETFs

1 - Strong Buy of 5 1        

Zacks News

Zacks Equity Research

The Zacks Analyst Blog Highlights: SPYV, SCHV, VTV, MGV, VONV and VOOV

The Zacks Analyst Blog Highlights: SPYV, SCHV, VTV, MGV, VONV and VOOV

Sweta Killa headshot

A Bunch of Dirt-Cheap Value ETFs to Buy Now

Honing in on lower expense ratio ETFs in the value space will be an ideal choice.

Sweta Jaiswal, FRM headshot

Value ETFs Looking Attractive Now: Let's Explore

Accelerated coronavirus vaccine rollout and rapid economic reopening may lead to faster U.S. economic recovery, making value ETFs an attractive investment option.

Sweta Jaiswal, FRM headshot

Bet on These Top Value ETFs Now

Several factors are creating a conducive environment for value stocks to outperform their growth counterparts this year.

Sweta Jaiswal, FRM headshot

Here's Why Investors Can Bet on These Value ETFs

Several factors are creating a conducive environment for value stocks to outperform their growth counterparts this year.

Sweta Jaiswal, FRM headshot

Top-Ranked Value ETFs to Add to Your Portfolio

Accelerated coronavirus vaccine rollout, a fresh round of fiscal stimulus and the economic reopening may lead to faster U.S. economic recovery and present a strong case for outperformance by value ETFs in 2021.

Sweta Killa headshot

Spread of Top-Ranked Value ETFs to Bet on Vaccine Optimism

The potential arrival of a coronavirus vaccine will end the pandemic crisis, keeping the economy recovery intact, and will boost consumer spending and in turn lift value stocks.

Sanghamitra Saha headshot

Is It Again Time to Shift Focus to Cyclical ETFs?

AstraZeneca has restarted British clinical trials of its COVID-19 vaccine. This piece of information may help boost cyclical ETFs all over again.

Sanghamitra Saha headshot

Don't Fear Correction: ETF Laggards Are Emerging Leaders

U.S. stocks were super steady in August as investors rotated into the beaten-down segments of the year ??? cyclicals.

Sanghamitra Saha headshot

Is a September Lull Inevitable? Play 6 ETFs

The S&P 500 posted its worst single-session drop in nearly three months mainly on profit booking. While high-flying tech names were hurt the most, laggards are better-positioned.